Shadowfax Technologies IPO
mainboardUpcoming
GMP
₹10
mainboardUpcoming
Shadowfax Technologies IPO
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹10
(+8.06%) Est. Gain
Investment Timeline
🔓
IPO Open
20 Jan 2026
🔒
IPO Close
22 Jan 2026
🎲
Allotment
23 Jan 2026
🔔
Listing
28 Jan 2026
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
NEUTRAL
55.8/100
🎯 Application Strategy
Action: ⚠️ NEUTRAL - Mixed signals, proceed with caution
Lots: Single lot only for diversification
⏳ Timing Advice
📊 Monitor subscription trends before applying
Key Factor Analysis
🚀
Demand
🚀 Exceptional subscription! Massive oversubscription across all categories
💰
Valuation
⚠️ Expensive valuation - limited room for gains
📈
Listing
⚠️ Limited listing gains expected (0-5%)
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹118.0 - ₹124.0
📦Lot Size
120 shares
💰Issue Size
₹1,907.27 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Shadowfax Technologies IPO?
As of today, the Grey Market Premium (GMP) for Shadowfax Technologies IPO is ₹10, which is approximately (+8.06%) of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Shadowfax Technologies IPO?
Our AI algorithm currently rates this IPO as "NEUTRAL" with a score of 55.8/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Shadowfax Technologies IPO be announced?
The allotment status for Shadowfax Technologies IPO is expected to be finalized on 23 Jan 2026. Investors can check their status on the registrar's website.
What is the listing date for Shadowfax Technologies IPO?
Shares of Shadowfax Technologies IPO are proposed to be listed on stock exchanges on 28 Jan 2026.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.